Physician profile
Lisa Chen
NPI 1003178021
$5,901.55
in general payments reported to CMS, 2019-2025
14 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,774 · 2020: $1,604 · 2021: $1,128 · 2022: $18.72 · 2023: $25.21 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,534.13 | 2019-2021 | |
| Alcon Vision LLC | $890.36 | 2019-2025 | Dailies Total1, Precision 1 |
| Allergan, INC. | $493.11 | 2019-2020 | |
| Shire North American Group INC | $471.25 | 2019 | |
| Eyevance Pharmaceuticals LLC | $395.51 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $275.52 | 2019 | |
| Coopervision INC. | $268.31 | 2019-2021 | |
| Rxsight INC | $206.31 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $137.24 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $124.32 | 2019 | |
| Genzyme Corporation | $50.00 | 2025 | |
| Bausch & Lomb Americas INC. | $22.32 | 2025 | Infuse |
| Sanofi Pasteur INC. | $18.56 | 2020 | |
| Alcon Research LLC | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.